Search hospitals > Texas > Dallas
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Claim this profileDallas, Texas 75246
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
427 reported clinical trials
25 medical researchers
Summary
Texas Oncology - Baylor Charles A. Sammons Cancer Center is a medical facility located in Dallas, Texas. This center is recognized for care of Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Tumors, Lung Cancer and other specialties. Texas Oncology - Baylor Charles A. Sammons Cancer Center is involved with conducting 427 clinical trials across 236 conditions. There are 25 research doctors associated with this hospital, such as Kristi McIntyre, MD, Noelle Cloven, MD, Joyce O'Shaughnessy, MD, and Moshe Levy.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
RET
Top PIs
Kristi McIntyre, MDTexas Oncology - Dallas Presbyterian Hospital3 years of reported clinical research
Expert in Breast Cancer
Studies Ovarian Cancer
26 reported clinical trials
52 drugs studied
Noelle Cloven, MDTexas Oncology-Fort Worth Cancer Center4 years of reported clinical research
Expert in Ovarian Cancer
Studies Ovarian Tumors
21 reported clinical trials
39 drugs studied
Joyce O'Shaughnessy, MDTexas Oncology-Baylor Charles A. Sammons Cancer Center7 years of reported clinical research
Expert in Breast Cancer
Studies Tumors
19 reported clinical trials
36 drugs studied
Moshe LevyTexas Oncology - Baylor Charles A. Sammons Cancer Center1 year of reported clinical research
Studies Leukemia
Studies Lymphoma
15 reported clinical trials
34 drugs studied
Clinical Trials running at Texas Oncology - Baylor Charles A. Sammons Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Prostate Cancer
Lymphoma
Follicular Lymphoma
Colorectal Cancer
Non-Hodgkin's Lymphoma
Lung Cancer
Tumors
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
Giredestrant vs. Fulvestrant
for Advanced Breast Cancer
This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Texas Oncology - Baylor Charles A. Sammons Cancer Center?
Texas Oncology - Baylor Charles A. Sammons Cancer Center is a medical facility located in Dallas, Texas. This center is recognized for care of Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Tumors, Lung Cancer and other specialties. Texas Oncology - Baylor Charles A. Sammons Cancer Center is involved with conducting 427 clinical trials across 236 conditions. There are 25 research doctors associated with this hospital, such as Kristi McIntyre, MD, Noelle Cloven, MD, Joyce O'Shaughnessy, MD, and Moshe Levy.
Where is Texas Oncology - Baylor Charles A. Sammons Cancer Center located?
**Texas Oncology-Baylor Charles A. Sammons Cancer Center**
- **Location:** 3410 Worth St., Suite 400, Dallas, TX 75246. Situated near the intersection of Hall and Worth Streets, behind Baylor University Medical Center.
- **Services:** Offers leading-edge chemotherapy, radiation therapy, and comprehensive care, focusing on treating the whole person, not just the disease.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries, contact Texas Oncology - Baylor Charles A. Sammons Cancer Center at (214) 821-4220. Baylor Scott & White Charles A. Sammons Cancer Center – Dallas provides financial solutions and accepts various insurance plans.
What insurance does Texas Oncology - Baylor Charles A. Sammons Cancer Center accept?
Baylor Scott & White Health, including Texas Oncology - Baylor Charles A. Sammons Cancer Center, has agreements with various insurance plans to cover patients' health needs. For detailed information, contact the hospital directly or visit their official website.
What awards or recognition has Texas Oncology - Baylor Charles A. Sammons Cancer Center received?
The Baylor Charles A. Sammons Cancer Center, located in Dallas, Texas and affiliated with Texas Oncology, is renowned for its groundbreaking research and clinical trials. This center offers patients access to innovative treatments and plays a significant role in advancing cancer care.